WayPoint Biomedical Holdings

WayPoint Biomedical Holdings was a medical diagnostics company that specialized in the development and commercialization of rapid, point-of-care testing solutions. The company primarily focused on lateral flow immunoassay technology for the detection of drugs of abuse and various infectious diseases. Its product portfolio included proprietary diagnostic kits designed for use in clinical, workplace, and home settings, providing results in minutes without the need for laboratory equipment. In 2006, the company's core assets and operations were acquired by Inverness Medical Innovations, which subsequently became part of Abbott Laboratories. WayPoint's technology contributed to the expansion of point-of-care testing platforms in the global healthcare market.